Related Experiment Videos
Anti-tumor effects of interferon and its possible use as an anti-neoplastic agent in man
Texas Reports on Biology and Medicine
|January 1, 1977
Abstract:
Interferon exerts anti-tumour effects in vitro and in vivo in animal experiments. It can also exert an anti-tumour effect on human neoplastic cells in vitro. This article summarizes the results obtained so far in the anti-tumour trials in man in Stockholm. The need for scaled-up production of human interferon is emphasized.
Insights
Interferon demonstrates anti-tumour capabilities in laboratory and animal studies. Clinical trials in humans in Stockholm are summarized, highlighting the need for increased human interferon production for further cancer research.
Area of Science:
- Oncology
- Immunology
Background:
- Interferon is known to possess anti-tumour properties demonstrated in preclinical models.
- Previous research indicates interferon's efficacy against neoplastic cells in vitro.
Purpose of the Study:
- To summarize the outcomes of anti-tumour trials involving human interferon conducted in Stockholm.
- To emphasize the necessity for enhanced production of human interferon for clinical applications.
Main Methods:
- Review of clinical trial data from Stockholm focusing on interferon therapy.
- Assessment of interferon's anti-tumour effects in human neoplastic cells in vitro and in vivo.
Main Results:
- Interferon has shown anti-tumour effects in various experimental settings.
- Clinical trial results from Stockholm are presented, detailing observed anti-tumour activity in human patients.
Conclusions:
- Human interferon exhibits therapeutic potential as an anti-cancer agent.
- There is a critical need to scale up the production of human interferon to meet clinical demands and facilitate further research.